Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Maurice Buchbinder"'
Autor:
Sukhdeep Bhogal, Ron Waksman, Paul Gordon, Afshin Ehsan, Sean R. Wilson, Robert Levitt, Puja Parikh, Thomas Bilfinger, Nicholas Hanna, Maurice Buchbinder, Federico M. Asch, Gaby Weissman, Itsik Ben-Dor, Christian C. Shults, Syed Ali, Corey Shea, Cheng Zhang, Hector M. Garcia-Garcia, Lowell F. Satler, Toby Rogers
Publikováno v:
International Journal of Cardiology. 371:305-311
Subclinical leaflet thrombosis (SLT) is characterized on computed tomography (CT) imaging as hypoattenuated leaflet thickening (HALT), reduced leaflet motion (RELM), and hypoattenuation affecting motion (HAM). How antithrombotic regimen type impacts
Autor:
Deepak L Bhatt, Muthiah Vaduganathan, David E Kandzari, Martin B Leon, Krishna Rocha-Singh, Raymond R Townsend, Barry T Katzen, Suzanne Oparil, Sandeep Brar, Vanessa DeBruin, Martin Fahy, George L Bakris, George Bakris, Sidney A Cohen, Ralph D'Agostino, Murray Esler, John Flack, Barry Katzen, Martin Leon, Laura Mauri, Manuela Negoita, Ray Townsend, Ziad Abbud, Tayo Addo, David Anderson, John Angle, Herbert Aronow, Anvar Babaev, Keith Benzuly, Somjot Brar, David Brown, David Calhoun, Paul Casale, Sheldon Chaffer, James Choi, Eugene Chung, Debbie L Cohen, Mark Creager, George Dangas, Harold Dauerman, Shukri David, Mark Davies, Eduardo de Marchena, Ali E Denktas, Chandan Devireddy, William Downey, Mark Dunlap, Daniel Fisher, Magdi Ghali, Eric Gnall, Raghava Gollapudi, Mark Goodwin, Nilesh Goswami, Luis Gruberg, Rajiv Gulati, Anuj Gupta, Anjan Gupta, Hitinder Gurm, Jeffrey Hastings, Scott Kinlay, Robert Kipperman, Maurice Buchbinder, Ajay Kirtane, Richard Kovach, David Lee, Samuel Mann, Steven Marso, Fadi Matar, Ernest Mazzaferri, Farrel Mandelsohn, Issam Moussa, Timothy Murphy, Sandeep Nathan, Brian Negus, Sahil Parikh, Manesh Patel, Kirikumar Patel, Basil Paulus, George Petrossian, Alex Powell, Jacek Preibisz, Florian Rader, Otelio Randall, Mahmood Razavi, John Reilly, Jonathan Reiner, Michael Ring, Mark Robbins, Kevin Rogers, Nicolas Ruggiero, Renato Santos, William Little, John Schindler, Thomas Scott, Thomas Shimshak, Mehdi Shishehbor, Mitchel Silver, Jasvindar Singh, Kanwar Singh, David Slovut, Rick G Stoufer, Paul Teirsten, Thomas Todoran, George Vetrovec, Ron Waksman, Yale Wang, Sergio Waxman, Robert Wilkins, Khaled Ziada, Frank Zidar
Publikováno v:
The Lancet. 400:1405-1416
The SYMPLICITY HTN-3 (Renal Denervation in Patients With Uncontrolled Hypertension) trial showed the safety but not efficacy of the Symplicity system (Medtronic, Santa Rosa, CA, USA) at 6 months follow-up in patients with treatment-resistant hyperten
Autor:
Giorgio Medranda Medranda, Cesar E. Soria Jimenez, Rebecca Torguson, Brian C. Case, Brian Forrestal Forrestal, Syed Ali Ali, Corey Shea, Cheng Zhang, John Wang Wang, Paul Gordon, Afshin Ehsan, Sean Wilson Wilson, Robert Levitt, Puja Parikh, Thomas Bilfinger, Nicholas Hanna, Maurice Buchbinder, Federico Asch Asch, Gaby Weissman, Christian Shults Shults, Hector M. Garcia-Garcia, Itsik Ben-Dor, Lowell Satler Satler, Ron Waksman, Toby Rogers
Publikováno v:
EuroIntervention. 18:e407-e416
Given enough time, transcatheter heart valves (THVs) will degenerate and may require reintervention. Redo transcatheter aortic valve implantation (TAVI) is an attractive strategy but carries a risk of coronary obstruction.We sought to predict how man
Autor:
Ron Waksman, Sukhdeep Bhogal, Paul Gordon, Afshin Ehsan, Sean R. Wilson, Robert Levitt, Puja Parikh, Thomas Bilfinger, Nicholas Hanna, Maurice Buchbinder, Federico M. Asch, Francis Y. Kim, Gaby Weissman, Itsik Ben-Dor, Christian C. Shults, Syed Ali, Joseph A. Sutton, Corey Shea, Cheng Zhang, Hector M. Garcia-Garcia, Lowell F. Satler, Toby Rogers
Publikováno v:
Circulation: Cardiovascular Interventions. 16
Background: The LRT trial (Low-Risk Transcatheter Aortic Valve Replacement [TAVR]) demonstrated the safety and feasibility of TAVR in low-risk patients, with excellent 1- and 2-year outcomes. The objective of the current study is to provide the overa
Autor:
Shephal K. Doshi, Saibal Kar, Ashish Sadhu, Rodney Horton, Jose Osorio, Christopher Ellis, James Stone, Manish Shah, Srinivas R. Dukkipati, Stuart Adler, Devi G. Nair, Jamie Kim, Oussama Wazni, Matthew J. Price, David R. Holmes, Robert Shipley, Thomas Christen, Dominic J. Allocco, Vivek Y. Reddy, Maurice Buchbinder, Larry Chinitz, David Delurgio, Amish Desai, Health Center, Shephal Doshi, Srinivas R. Dukkipatti, Douglas Gibson, David Holmes, Kenneth Huber, Farhat Khairallah, Jayanthi Koneru, Paul Mahoney, Moussa Mansour, George Mark, Devi Nair, William O’Neill, William Nicholson, James Reiss, Walid Saliba, Michael Shehata, Vijendra Swarup
Publikováno v:
Journal of the American Heart Association. 12
Background The PINNACLE FLX (Protection Against Embolism for Non‐valvular AF [Atrial Fibrillation] Patients: Investigational Device Evaluation of the Watchman FLX LAA [Left Atrial Appendage] Closure Technology) trial evaluated the safety and effica
Autor:
David G. Rizik, Vivek Rajagopal, Raj R. Makkar, Tanvir Bajwa, Neal S. Kleiman, Axel Linke, Dean J. Kereiakes, Ron Waksman, Vinod H. Thourani, Robert C. Stoler, Gregory J. Mishkel, Vijay S. Iyer, Maurice Buchbinder, Matthias Götberg, Henrik Bjursten, Dominic J. Allocco, Michael J. Reardon
Publikováno v:
JAMA network open. 5(10)
ImportanceLong-term follow-up after transcatheter aortic valve replacement (TAVR) is of interest given that longitudinal data on mortality and durability of transcatheter heart valves are limited. The REPRISE III (Repositionable Percutaneous Replacem
Autor:
Nicholas Hanna, Thomas V. Bilfinger, Paul C. Gordon, Scott Buchanan, Toby Rogers, Ron Waksman, Giorgio A. Medranda, Cheng Zhang, Itsik Ben-Dor, Rebecca Torguson, Corey Shea, Hector M. Garcia-Garcia, Gaby Weissman, Maurice Buchbinder, Sean R. Wilson, Federico M. Asch, Robert Levitt, Lowell F. Satler, Afshin Ehsan, Christian Shults, Chiwon Hahn, David Butzel, Puja B. Parikh
Publikováno v:
American Heart Journal. 237:25-33
Background Previous studies from the Low Risk TAVR (LRT) trial demonstrated that transcatheter aortic valve replacement (TAVR) is safe and feasible in low-risk patients, with excellent 30-day and 1-year outcomes. The objective of this study was to re
Autor:
Colin O'Donnell, Leo Gozdecki, Hani Jneid, Subhash Banerjee, Kul Aggarwal, Anthony A. Bavry, Stefan C. Bertog, John C. Giacomini, Kendrick A. Shunk, Philip S. Hall, Jeffrey M. Zimmet, Paul M. Grossman, Elaine E. Tseng, Santiago Garcia, Stephen W. Waldo, Ali E. Denktas, Mary E. Plomondon, Maurice Buchbinder, Lucas Burke, Verghese Mathew
Publikováno v:
JACC: Cardiovascular Interventions. 12:2186-2194
Objectives This study sought to describe clinical and procedural characteristics of veterans undergoing transcatheter aortic valve replacement (TAVR) within U.S. Department of Veterans Affairs (VA) centers and to examine their association with short-
Autor:
Sukhdeep Bhogal, Rebecca Torguson, Paul Gordon, Afshin Ehsan, Sean R. Wilson, Robert Levitt, Puja Parikh, Thomas Bilfinger, Nicholas Hanna, Maurice Buchbinder, Federico M. Asch, Gaby Weissman, Itsik Ben-Dor, Christian C. Shults, Syed Ali, Corey Shea, Cheng Zhang, Hector M. Garcia-Garcia, Ron Waksman, Toby Rogers
Publikováno v:
Cardiovascular Revascularization Medicine. 40:103-104
Autor:
Sukhdeep Bhogal, Rebecca Torguson, Paul Gordon, Afshin Ehsan, Sean R. Wilson, Robert Levitt, Puja Parikh, Thomas Bilfinger, Nicholas Hanna, Maurice Buchbinder, Federico M. Asch, Gaby Weissman, Itsik Ben-Dor, Christian C. Shults, Syed Ali, Corey Shea, Cheng Zhang, Hector M. Garcia-Garcia, Lowell F. Satler, Ron Waksman, Toby Rogers
Publikováno v:
Cardiovascular Revascularization Medicine. 40:104-105